EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Development of a Risk Model and Genotyping Patterns Based on Disulfidptosis-Related lncRNAs to Predict Prognosis and Immune Landscape in Osteosarcoma

Ke Zhang, Shenyi Lu, Mingyang Jiang, Xiaochong Zou, Chuanliang Chen, Yuanyuan Lan, Huaan Zhao, Ruilan Ma, Haiwei Yan

Frontiers in Bioscience-Landmark · 2024

DOI: 10.31083/j.fbl2905193 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Frontiers in Bioscience-Landmark, 2024. Verfasst von Ke Zhang und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Bone and Joint Surgery, First Affiliated Hospital of Guangxi Medical University, 530021 Nanning, Guangxi, China. Hauptthemen laut MEDLINE: Osteosarcoma, RNA, Long Noncoding, Bone Neoplasms, Gene Expression Regulation, Neoplastic. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Osteosarcoma (OS) is the most prevalent orthopedic malignancy with a dismal prognosis. Disulfidptosis-related lncRNAs (DRLncs) may be related to the progression of OS, but their potential molecular regulatory role is still unclear.

Methods

Based on the data collected from The Cancer Genome Atlas (TCGA), we conducted correlation analysis and the univariate Cox analysis to screen prognosis-related DRLncs, followed by developing genotyping patterns and corresponding classifier. Subsequently, the survival analysis, enrichment analysis, drug sensitivity analysis and immune infiltration analysis were performed. Afterward, multivariate Cox regression was used to construct a risk model, which was further validated by the receiver operating characteristic (ROC) curve. The aberrant expression of hub DRLncs in OS was validated using the Reverse Transcription Polymerase Chain Reaction (RT-qPCR) assay.

Results

We identified 262 DRLncs and eleven prognosis-related DRLncs through filtering. We then constructed two distinct expression patterns of prognosis-related DRLncs and developed a classifier. We obtained 393 differentially expressed genes (DEGs) between different subtypes, which were significantly enriched in biological processes related to the extracellular matrix, integrin binding, focal adhesion, and Wnt signaling pathways. Through immune infiltration analysis, the activated CD4 memory T cells, resting natural killer (NK) cells, M1 macrophages, and resting dendritic cells (DC) were observed to exhibit different abundance in distinct subtypes. In the drug sensitivity analysis, tamoxifen showed a promising effect for drug-resistant OS. Furthermore, we identified five hub DRLncs and constructed a risk model. The RT-qPCR confirmed the aberrant expression of five hub DRLncs in OS.

Conclusions

The present study identified DRLncs in OS, and conducted a comprehensive investigation of DRLncs-related expression patterns, survival status, immune landscape and drug sensitivity to reveal the difference in prognostic, pharmacological and immunological phenotype characteristics between distinct subtypes. Additionally, we developed a risk model to predict the prognosis, and constructed a genotyping classifier to predict the above phenotype characteristics in OS.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

OsteosarcomaRNA, Long NoncodingBone NeoplasmsGene Expression Regulation, NeoplasticHumansPrognosisBiomarkers, TumorGenotypeGene Expression ProfilingTumor MicroenvironmentFemaleMale

Stichwörter der Autor:innen

disulfidptosisimmune landscapelncRNAosteosarcomaprognostic model

Substanzen

RNA, Long NoncodingBiomarkers, Tumor

Autor:innen und Institutionen

  • Department of Bone and Joint Surgery, First Affiliated Hospital of Guangxi Medical University, 530021 Nanning, Guangxi, China.
  • Department of Rehabilitation Medicine, The Affiliated Hospital of Youjiang Medical University for Nationalities, 533000 Baise, Guangxi, China.
  • School of Basic Medical Sciences, Guangxi Medical University, 530021 Nanning, Guangxi, China.
  • Department of Sports Medicine, Fourth Affiliated Hospital of Guangxi Medical University/Liuzhou Worker's Hospital, 545000 Liuzhou, Guangxi, China.

Zitieren

APA

Zhang, K., Lu, S., Jiang, M., Zou, X., Chen, C., Lan, Y., Zhao, H., Ma, R., & Yan, H. (2024). Development of a Risk Model and Genotyping Patterns Based on Disulfidptosis-Related lncRNAs to Predict Prognosis and Immune Landscape in Osteosarcoma. Frontiers in Bioscience-Landmark. https://doi.org/10.31083/j.fbl2905193

Vancouver

Zhang K, Lu S, Jiang M, Zou X, Chen C, Lan Y, et al. Development of a Risk Model and Genotyping Patterns Based on Disulfidptosis-Related lncRNAs to Predict Prognosis and Immune Landscape in Osteosarcoma. Frontiers in Bioscience-Landmark. 2024. doi:10.31083/j.fbl2905193

BibTeX
@article{Zhang2024,
  author = {Zhang, Ke and Lu, Shenyi and Jiang, Mingyang and Zou, Xiaochong and Chen, Chuanliang and Lan, Yuanyuan and Zhao, Huaan and Ma, Ruilan and Yan, Haiwei},
  title = {Development of a Risk Model and Genotyping Patterns Based on Disulfidptosis-Related lncRNAs to Predict Prognosis and Immune Landscape in Osteosarcoma},
  journal = {Frontiers in Bioscience-Landmark},
  year = {2024},
  doi = {10.31083/j.fbl2905193}
}
Kostenlos starten →